1
|
Chaudhry GES, Zeenia, Sharifi-Rad J, Calina D. Hispidulin: a promising anticancer agent and mechanistic breakthrough for targeted cancer therapy. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY 2024; 397:1919-1934. [PMID: 37594522 DOI: 10.1007/s00210-023-02645-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Accepted: 07/25/2023] [Indexed: 08/19/2023]
Abstract
Cancer is a complex disease characterized by dysregulated cell growth and division, posing significant challenges for effective treatment. Hispidulin, a flavonoid compound, has shown promising biological effects, particularly in the field of anticancer research. The main objective of this study is to investigate the anticancer properties of hispidulin and gain insight into its mechanistic targets in cancer cells. A comprehensive literature review was conducted to collect data on the anticancer effects of hispidulin. In vitro and in vivo studies were analyzed to identify the molecular targets and underlying mechanisms through which hispidulin exerts its anticancer activities. Hispidulin has shown significant effects on various aspects of cancer, including cell growth, proliferation, cell cycle regulation, angiogenesis, metastasis, and apoptosis. It has been observed to target both extrinsic and intrinsic apoptotic pathways, regulate cell cycle arrest, and modulate cancer progression pathways. The existing literature highlights the potential of hispidulin as a potent anticancer agent. Hispidulin exhibits promising potential as a therapeutic agent for cancer treatment. Its ability to induce apoptosis and modulate key molecular targets involved in cancer progression makes it a valuable candidate for further investigation. Additional pharmacological studies are needed to fully understand the specific targets and signaling pathways influenced by hispidulin in different types of cancer. Further research will contribute to the successful translation of hispidulin into clinical settings, allowing its utilization in conventional and advanced cancer therapies with improved therapeutic outcomes and reduced side effects.
Collapse
Affiliation(s)
- Gul-E-Saba Chaudhry
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Terengganu, Malaysia.
| | - Zeenia
- Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Terengganu, Malaysia
| | | | - Daniela Calina
- Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania.
| |
Collapse
|
2
|
Yan S, Xie M, Wang Y, Xiao Q, Ding N, Li Y. Semi-synthesis of a series natural flavonoids and flavonoid glycosides from scutellarin. Tetrahedron 2020. [DOI: 10.1016/j.tet.2020.130950] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
3
|
Li HM, Gu T, Wu WY, Yu SP, Fan TY, Zhong Y, Li NG. Synthesis and Biological Evaluation of Scutellarein Alkyl Derivatives as Preventing Neurodegenerative Agents with Improved Lipid Soluble Properties. Med Chem 2018; 15:771-780. [PMID: 30324887 DOI: 10.2174/1573406414666181015143551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2018] [Revised: 09/06/2018] [Accepted: 10/01/2018] [Indexed: 11/22/2022]
Abstract
BACKGROUND Exogenous antioxidants are considered as a promising therapeutic approach to treat neurodegenerative diseases since they could prevent and/or minimize the neuronal damage by oxidation. OBJECTIVE Three series of lipophilic compounds structurally based on scutellarein (2), which is one metabolite of scutellarin (1) in vivo, have been designed and synthesized. METHODS Their antioxidant activity was evaluated by detecting the 2-thiobarbituric acid reactive substance (TBARS) produced in the ferrous salt/ascorbate-induced autoxidation of lipids, which were present in microsomal membranes of rat hepatocytes. The lipophilicity of these compounds indicated as partition coefficient between n-octanol and buffer was investigated by ultraviolet (UV) spectrophotometer. RESULTS This study indicated that compound 5e which had a benzyl group substituted at the C4'- OH position showed a potent antioxidant activity and good lipophilicity. CONCLUSION 5e could be an effective candidate for preventing or reducing the oxidative status associated with the neurodegenerative processes.
Collapse
Affiliation(s)
- He-Min Li
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
| | - Ting Gu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
| | - Wen-Yu Wu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
| | - Shao-Peng Yu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
| | - Tian-Yuan Fan
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
| | - Yue Zhong
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
| | - Nian-Guang Li
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China
| |
Collapse
|
4
|
Chen LC, Hsu KC, Chiou LC, Tseng HJ, Huang WJ. Total Synthesis and Metabolic Stability of Hispidulin and Its d-Labelled Derivative. Molecules 2017; 22:molecules22111897. [PMID: 29113055 PMCID: PMC6150239 DOI: 10.3390/molecules22111897] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 11/01/2017] [Accepted: 11/02/2017] [Indexed: 12/15/2022] Open
Abstract
Hispidulin is a naturally occurring flavone known to have various Central nervous system (CNS) activities. Proposed synthetic approaches to synthesizing hispidulin have proven unsatisfactory due to their low feasibility and poor overall yields. To solve these problems, this study developed a novel scheme for synthesizing hispidulin, which had an improved overall yield as well as more concise reaction steps compared to previous methods reported. Additionally, using the same synthetic strategy, d-labelled hispidulin was synthesized to investigate its metabolic stability against human liver microsome. This work may produce new chemical entities for enriching the library of hispidulin-derived compounds.
Collapse
Affiliation(s)
- Liang-Chieh Chen
- Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
| | - Kai-Cheng Hsu
- Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.
| | - Lih-Chu Chiou
- Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei 110, Taiwan.
- Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
| | - Hui-Ju Tseng
- Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
- Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
| | - Wei-Jan Huang
- Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
- Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
- Program for the Clinical Drug Discovery from Botanical Herbs, Taipei 110, Taiwan.
- School of Pharmacy, National Defense Medical Center, Taipei 114, Taiwan.
| |
Collapse
|
5
|
Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia. Neuromolecular Med 2016; 18:264-73. [PMID: 27103430 DOI: 10.1007/s12017-016-8394-x] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2016] [Accepted: 04/04/2016] [Indexed: 12/26/2022]
Abstract
The cerebral ischemia is one of the most common diseases in the central nervous system that causes progressive disability or even death. In this connection, the inflammatory response mediated by the activated microglia is believed to play a central role in this pathogenesis. In the event of brain injury, activated microglia can clear the cellular debris and invading pathogens, release neurotrophic factors, etc., but in chronic activation microglia may cause neuronal death through the release of excessive inflammatory mediators. Therefore, suppression of microglial over-reaction and microglia-mediated neuroinflammation is deemed to be a therapeutic strategy of choice for cerebral ischemic damage. In the search for potential herbal extracts that are endowed with the property in suppressing the microglial activation and amelioration of neuroinflammation, attention has recently been drawn to scutellarin, a Chinese herbal extract. Here, we review the roles of activated microglia and the effects of scutellarin on activated microglia in pathological conditions especially in ischemic stroke. We have further extended the investigation with special reference to the effects of scutellarin on Notch signaling, one of the several signaling pathways known to be involved in microglial activation. Furthermore, in light of our recent experimental evidence that activated microglia can regulate astrogliosis, an interglial "cross-talk" that was amplified by scutellarin, it is suggested that in designing of a more effective therapeutic strategy for clinical management of cerebral ischemia both glial types should be considered collectively.
Collapse
|
6
|
Dong ZX, Shi ZH, Li NG, Zhang W, Gu T, Zhang PX, Wu WY, Tang YP, Fang F, Xue X, Li HM, Cheng HB, Yang JP, Duan JA. Design, Synthesis, and Biological Evaluation of Scutellarein Derivatives Based on Scutellarin Metabolic MechanismIn Vivo. Chem Biol Drug Des 2016; 87:946-57. [DOI: 10.1111/cbdd.12727] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2015] [Revised: 12/11/2015] [Accepted: 12/30/2015] [Indexed: 11/29/2022]
Affiliation(s)
- Ze-Xi Dong
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Zhi-Hao Shi
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
- Department of Organic Chemistry; China Pharmaceutical University; Nanjing Jiangsu 211198 China
| | - Nian-Guang Li
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Wei Zhang
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Ting Gu
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Peng-Xuan Zhang
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Wen-Yu Wu
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Yu-Ping Tang
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Fang Fang
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Xin Xue
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - He-Min Li
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Hai-Bo Cheng
- Key Laboratory of SATCM for Empirical Formulae Evaluation and Achievements Transformation; Nanjing University of Chinese Medicine; Nanjing Jiangsu 210023 China
| | - Jian-Ping Yang
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| | - Jin-Ao Duan
- Jiangsu Key Laboratory for High Technology Research of TCM Formulae; Jiangsu Collaborative Innovation Center of Chinese Medicine Resources Industrialization; National and Local Collaborative Engineering Center of Chinese Medicine Resources; Nanjing University of Chinese Medicine; Nanjing 210023 China
| |
Collapse
|